119 related articles for article (PubMed ID: 8586805)
1. A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries.
Shaw LM; George PR; Oldham AA; Heagerty AM
J Hypertens; 1995 Oct; 13(10):1135-43. PubMed ID: 8586805
[TBL] [Abstract][Full Text] [Related]
2. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
Li JS; Sharifi AM; Schiffrin EL
J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
[TBL] [Abstract][Full Text] [Related]
3. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
Brilla CG; Matsubara L; Weber KT
Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
[TBL] [Abstract][Full Text] [Related]
4. Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
Mori T; Nishimura H; Ueyama M; Kubota J; Kawamura K
Jpn Circ J; 1995 Sep; 59(9):624-30. PubMed ID: 7500546
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy.
Rizzoni D; Muiesan ML; Porteri E; Castellano M; Zulli R; Bettoni G; Salvetti M; Monteduro C; Agabiti-Rosei E
J Hypertens; 1997 Feb; 15(2):197-204. PubMed ID: 9469796
[TBL] [Abstract][Full Text] [Related]
6. Effect of an angiotensin II receptor antagonist, TCV-116, on neointimal formation following balloon injury in the SHR carotid artery.
Kino H; Hama J; Takenaka T; Sugimura K; Kamoi K; Shimada S; Yamamoto Y; Nagata S; Kai T; Horiuchi M
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S360-2. PubMed ID: 9072428
[TBL] [Abstract][Full Text] [Related]
7. Additional salutary effects of the combination of exercise training and an angiotensin-converting enzyme inhibitor on the left ventricular function of spontaneously hypertensive rats.
Ziada AM
J Hypertens; 2009 Jun; 27(6):1309-16. PubMed ID: 19462500
[TBL] [Abstract][Full Text] [Related]
8. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
Oddie CJ; Dilley RJ; Kanellakis P; Bobik A
J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
[TBL] [Abstract][Full Text] [Related]
9. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
Minami N; Head GA
J Hypertens; 1993 May; 11(5):523-33. PubMed ID: 8390524
[TBL] [Abstract][Full Text] [Related]
10. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
Intengan HD; Thibault G; Li JS; Schiffrin EL
Circulation; 1999 Nov; 100(22):2267-75. PubMed ID: 10578002
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
13. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.
Brilla CG; Janicki JS; Weber KT
Circulation; 1991 May; 83(5):1771-9. PubMed ID: 1850668
[TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
Nakano N; Moriguchi A; Morishita R; Kida I; Tomita N; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Hypertension; 1997 Dec; 30(6):1448-54. PubMed ID: 9403566
[TBL] [Abstract][Full Text] [Related]
15. Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats.
Koffi I; Lacolley P; Kirchengaast M; Pomiès JP; Laurent S; Benetos A
Eur J Pharmacol; 1998 Nov; 361(1):51-60. PubMed ID: 9851541
[TBL] [Abstract][Full Text] [Related]
16. Importance of cardiac, but not vascular, hypertrophy in the cardiac baroreflex deficit in spontaneously hypertensive and stroke-prone rats.
Head GA; Minami N
Am J Med; 1992 Apr; 92(4B):54S-59S. PubMed ID: 1533747
[TBL] [Abstract][Full Text] [Related]
17. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
Rizzoni D; Porteri E; Bettoni G; Piccoli A; Castellano M; Muiesan ML; Pasini G; Guelfi D; Rosei EA
J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
[TBL] [Abstract][Full Text] [Related]
18. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
Pu Q; Larouche I; Schiffrin EL
Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
[TBL] [Abstract][Full Text] [Related]
19. Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats.
Linz W; Heitsch H; Schölkens BA; Wiemer G
Hypertension; 2000 Apr; 35(4):908-13. PubMed ID: 10775560
[TBL] [Abstract][Full Text] [Related]
20. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.
Gillies LK; Lu M; Wang H; Lee RM
Hypertension; 1997 Dec; 30(6):1471-8. PubMed ID: 9403569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]